Dynavax (DVAX) Stock Statistics & Valuation Metrics

Dynavax has a market cap or net worth of $1.21B. The enterprise value is $996.54M.

Dynavax has 117,267,480 shares outstanding. The number of shares has decreased by -2.65% in one year.

Dynavax’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is -0.40%.

The current PE Ratio of Dynavax is ―. Dynavax’s PEG ratio is -0.12.

In the last 12 months, Dynavax had revenue of 277.25M and earned 27.31M in profits. Earnings per share was 0.21.

In the last 12 months, operating cash flow was 90.63M and capital expenditures -10.10M, giving a free cash flow of 80.54M billion.

Dynavax pays an annual dividend of ―, resulting in a dividend yield of ―

Dynavax upcoming earnings date is Feb 19, 2026, After Close (Confirmed).

Dynavax as a current ratio of 10.80, with Debt / Equity ratio of 57.77%

In the past 12 months, Dynavax has paid 3.55M in taxes.

Dynavax EV to EBITDA ratio is 39.81, with an EV/FCF ratio of 30.24.

Dynavax has $647.82M in cash and marketable securities with $285.02M in debt, giving a net cash position of $362.79M billion.

Gross margin is 82.83%, with operating margin of -1.49%, and net profit margin of 9.85%.

The average price target for Dynavax is $21.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy